tiprankstipranks
Trending News
More News >
Organo Corp. (JP:6368)
:6368
Japanese Market

Organo Corp. (6368) AI Stock Analysis

Compare
0 Followers

Top Page

JP

Organo Corp.

(6368)

Rating:73Outperform
Price Target:
¥9,701.00
▲(8.39%Upside)
Organo Corp.'s strong financial performance and stable valuation are significant positives, supporting the stock's attractiveness. While technical indicators suggest overbought conditions, they also confirm strong momentum, which could sustain upward price movement in the medium term.

Organo Corp. (6368) vs. iShares MSCI Japan ETF (EWJ)

Organo Corp. Business Overview & Revenue Model

Company DescriptionOrgano Corp. (6368) is a leading Japanese company specializing in water treatment solutions and chemical products. It operates primarily in the industrial, environmental, and municipal sectors, offering a wide range of products and services that include water purification systems, wastewater treatment, and various chemical solutions. The company's core offerings are designed to help industries achieve efficient water usage and compliance with environmental regulations.
How the Company Makes MoneyOrgano Corp. generates revenue through the sale and service of its water treatment systems and chemical products. Its key revenue streams include the installation and maintenance of water purification and wastewater treatment systems for industrial clients, as well as the sale of specialized chemical products used in these processes. The company also engages in long-term service contracts with municipal and environmental clients, providing ongoing system maintenance and operational support. Additionally, strategic partnerships with other industrial firms and government entities enhance its market reach and contribute to sustained earnings.

Organo Corp. Financial Statement Overview

Summary
Organo Corp. exhibits strong financial performance with robust revenue growth, improved profit margins, solid equity position, and effective cash flow management, positioning it well for future growth.
Income Statement
85
Very Positive
Organo Corp. has shown strong revenue growth, with a consistent increase in total revenue over the years, indicating a positive trajectory. The gross profit margin has improved, reflecting efficient cost management. Notably, the net profit margin has strengthened markedly, showcasing enhanced profitability. EBIT and EBITDA margins have also shown consistent improvement, underscoring robust operational performance.
Balance Sheet
78
Positive
The balance sheet of Organo Corp. reveals a solid equity position, with a favorable equity ratio indicating financial stability. The debt-to-equity ratio is within a reasonable range, suggesting manageable leverage levels. Additionally, the company has shown a strong return on equity, reflecting effective utilization of shareholder funds and solid profitability.
Cash Flow
76
Positive
Organo Corp.'s cash flow statement indicates a strong recovery in operating cash flow, supporting a positive free cash flow trend. The operating cash flow to net income ratio is robust, confirming effective cash conversion. Meanwhile, the free cash flow to net income ratio has improved, signaling efficient capital management despite past fluctuations.
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue159.82B163.27B150.36B132.43B112.07B100.64B
Gross Profit51.31B55.18B43.84B34.98B28.51B26.33B
EBITDA30.97B34.53B25.88B17.04B12.18B10.79B
Net Income21.03B24.15B17.31B11.73B9.21B7.07B
Balance Sheet
Total Assets178.97B194.40B182.70B164.85B130.51B115.01B
Cash, Cash Equivalents and Short-Term Investments47.17B16.75B17.64B25.41B31.49B22.58B
Total Debt38.33B22.56B36.47B33.02B15.63B16.00B
Total Liabilities84.45B73.20B80.56B78.48B54.50B47.65B
Stockholders Equity94.28B120.95B101.93B86.17B75.84B67.21B
Cash Flow
Free Cash Flow0.0026.54B2.08B-19.99B7.99B-5.84B
Operating Cash Flow0.0028.80B3.73B-18.54B10.79B-4.58B
Investing Cash Flow0.00-2.13B-1.42B-1.31B-1.52B-1.26B
Financing Cash Flow0.00-20.82B-641.00M14.71B-2.59B4.93B

Organo Corp. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price8950.00
Price Trends
50DMA
7838.40
Positive
100DMA
7224.98
Positive
200DMA
7541.40
Positive
Market Momentum
MACD
348.46
Negative
RSI
70.94
Negative
STOCH
71.25
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6368, the sentiment is Positive. The current price of 8950 is above the 20-day moving average (MA) of 8472.00, above the 50-day MA of 7838.40, and above the 200-day MA of 7541.40, indicating a bullish trend. The MACD of 348.46 indicates Negative momentum. The RSI at 70.94 is Negative, neither overbought nor oversold. The STOCH value of 71.25 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6368.

Organo Corp. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (71)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
¥45.61B9.1013.39%1.95%23.92%-9.51%
77
Outperform
¥80.49B14.218.79%2.35%8.17%-0.38%
76
Outperform
$644.61B31.756.03%1.60%6.25%-30.48%
76
Outperform
¥85.96B13.09
5.13%12.10%148.20%
73
Outperform
¥410.71B17.04
1.99%8.59%39.41%
71
Outperform
$159.92B15.349.36%3.72%1.34%20.86%
71
Outperform
¥252.71B13.078.49%3.07%6.30%13.10%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:6368
Organo Corp.
8,860.00
1,145.51
14.85%
JP:6332
TSUKISHIMA HOLDINGS CO. LTD.
2,046.00
611.56
42.63%
JP:6331
Mitsubishi Kakoki Kaisha,Ltd.
1,946.00
552.55
39.65%
JP:9551
METAWATER Co
2,232.00
336.78
17.77%
JP:6370
Kurita Water Industries
5,697.00
-1,212.33
-17.55%
JP:6013
Takuma Co
2,029.00
303.37
17.58%

Organo Corp. Corporate Events

Organo Corporation Transfers Shares to Enhance Indonesian Water Treatment Venture
Jan 30, 2025

Organo Corporation announced its decision to transfer part of its shareholding in its Indonesian joint venture, PT Lautan Organo Water, to its partner’s subsidiary, PT Lautan Air Indonesia. This move is aimed at boosting the synergy and growth potential of the water treatment business in Indonesia, following slower than expected growth. Organo Corporation will retain a 30% stake in the venture, continuing its involvement in the water treatment sector while optimizing its business portfolio.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 26, 2025